Form 4: Director Donald Zurbay Receives RSU Grant at Dentsply Sirona

Director Donald Zurbay acquired 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity grant.

Summary

• Director Donald Zurbay was granted 22,822 Restricted Stock Units (RSUs) on June 3, 2026.
• The grant was issued at a price of $0 per share.
• Following this transaction, Zurbay's total beneficial ownership of Dentsply Sirona common stock increased to 29,693 shares.
• The RSUs are scheduled to vest in full one year from the date of the grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in nature.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified in this filing.

Risks

• Standard market risks associated with equity ownership in Dentsply Sirona Inc.

Future Outlook

The RSUs are subject to a one-year vesting period, after which the restrictions will lapse.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard corporate governance practice designed to incentivize long-term performance and align board members with shareholder interests.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices among large-cap healthcare and medical device companies.
• The one-year vesting schedule is a common retention and alignment mechanism for board members.

Stakeholder Impact

• Shareholders: Increased alignment between director incentives and company performance.

Next Steps

• Vesting of the 22,822 RSUs on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Director Compensation